US Food and Drug Administration authorizes booster dose of Pfizer vaccine

The US Food and Drug Administration on Wednesday authorized a booster dose of the Pfizer Inc (PFE.N) COVID-19 vaccine for those aged 65 and older and some high-risk Americans, paving the way for a quick rollout of the shots.